Stay updated on Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial page.

Latest updates to the Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedConsolidated Locations section now lists study sites across multiple regions (US states and international sites such as Alberta, Ontario, Quebec, and Málaga), replacing the previous state-by-state location blocks. This change improves visibility of where the study is conducted and affects how users identify nearby sites.SummaryDifference1%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 was removed. This is a minor metadata update with no impact on study details.SummaryDifference0.0%

- Check44 days agoChange DetectedPublications section wording updated to specify automatic filling from PubMed and the new revision tag v3.3.1. The previous wording about PubMed-derived publications and the older v3.2.0 revision has been removed.SummaryDifference0.0%

- Check51 days agoChange DetectedRemoved the government funding status notice from the page, and study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check65 days agoChange DetectedThe Participating Locations section has been updated to reflect changes in sites across multiple states and countries. This may affect where patients can enroll and access trial information.SummaryDifference0.2%

- Check94 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference2%

Stay in the know with updates to Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial page.